Heartbeam CEO Eno Transitions to Consulting Role as Part of Reorganization

Dow Jones06-25 05:23

HeartBeam said Chief Executive Robert Eno will transition to a consulting role in a reorganization that will involve licensing its ECG signal technology out for heart attack detection.

The medical technology company said its reorganization will be led by its President Branislav Vajdic and Board Chairman Rich Ferrari.

Vajdic said that in addition to expanding its ECG technology, the company will continue to focus on previously announced clinical studies to accelerate the development of their heart attack detection platform.

HeartBeam said artificial intelligence accelerated the development of its ECG platform and a central focus of its new strategy would be to expand its platform beyond arrhythmia assessment to reliable heart attack detection.

It added that it intends to achieve global adoption by partnering with governments, health systems, and various manufacturers.

Write to Grace Yoon at grace.yoon@wsj.com

(END) Dow Jones Newswires

June 24, 2026 17:23 ET (21:23 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment